Identification and characterization of anti-chikungunya virus compounds using a biosafe toolkit. [PDF]
Gao Y +8 more
europepmc +1 more source
Antifungal resistance and poor clinical outcome rates of <i>Candida auris</i> in mainland China: A systematic review and meta-analysis. [PDF]
Xu T, Wang R, Gao Y, Yang L.
europepmc +1 more source
First Isolation of <i>Candida parapsilosis</i> from Water-Related Domestic Environments in Colombia: A Public Health Concern? [PDF]
Vélez N +5 more
europepmc +1 more source
<i>Candida glabrata</i> species complex in a Brazilian public tertiary hospital: site of infection, identification and antifungal susceptibility profile. [PDF]
Cândido MFF +9 more
europepmc +1 more source
Fragility of Observed Associations in Selection of Empirical Antifungal Therapy for Critically Ill Non-Neutropenic Patients [Letter]. [PDF]
Manzoor S, Giacobbe DR, Chow R.
europepmc +1 more source
Multicenter evaluation of low inoculum and a colorimetric assay for antifungal susceptibility testing of <i>Aspergillus fumigatus</i> to echinocandins with the EUCAST E.Def 9.4. [PDF]
Meletiadis J +5 more
europepmc +1 more source
Evaluation of Sensititre YeastOne for antifungal susceptibility testing of <i>Candida (Candidozyma) auris</i>: misclassification of <i>FKS1</i> mutants and overestimation of caspofungin resistance in a global collection of isolates. [PDF]
Siopi M +11 more
europepmc +1 more source
<i>Candidozyma auris</i> susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents. [PDF]
Klamer KS +4 more
europepmc +1 more source
Predictors of <i>Candida auris</i> Infection in Previously Colonized Patients: A Retrospective Cohort Study from a Large Tertiary Reference Center. [PDF]
Ergün N +4 more
europepmc +1 more source

